Dr. LeBeaut is a pediatrician with extensive global research and development expertise, including more than 25 years in the biopharmaceutical industry. He most recently served as Executive Vice President of Research and Development and Chief Scientific Officer at IPSEN BioScience in Cambridge, MA. Alex has a distinguished career in global drug development, having previously held senior leadership positions at Bluebird Bio, Axcan Pharmaceuticals, Sanofi, Novartis, and Schering-Plough Research Institute. Throughout his career, he contributed to develop and successfully bring to patients therapeutic solutions in medical areas including oncology, infectious diseases, pediatrics, genetic diseases, gastroenterology, cardio-metabolic, and neurological disorders.
Dr. LeBeaut received his MD from Paris Diderot University in France and trained in Pediatrics at Paris Descartes University and began his career as a resident fellow in general pediatric and intensive care units in Paris.